These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20335020)

  • 1. Actionable indicators for short and long term outcomes in rectal cancer.
    Gort M; Otter R; Plukker JT; Broekhuis M; Klazinga NS
    Eur J Cancer; 2010 Jul; 46(10):1808-14. PubMed ID: 20335020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands.
    Elferink MA; Krijnen P; Wouters MW; Lemmens VE; Jansen-Landheer ML; van de Velde CJ; Langendijk JA; Marijnen CA; Siesling S; Tollenaar RA
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S74-82. PubMed ID: 20598844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors.
    Bufalari A; Giustozzi G; Burattini MF; Servili S; Bussotti C; Lucaroni E; Ricci E; Sciannameo F
    J Surg Oncol; 2006 Mar; 93(3):173-80. PubMed ID: 16482596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
    Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; Schrag D; Ayanian JZ; O'Connell MJ; Weeks JC; Mayer RJ; Willett CG; MacDonald JS; Benson AB; Fuchs CS
    J Clin Oncol; 2004 Jan; 22(1):166-74. PubMed ID: 14701779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of colon cancer outcomes in hospitals with a high percentage of Medicaid patients.
    Rhoads KF; Ackerson LK; Jha AK; Dudley RA
    J Am Coll Surg; 2008 Aug; 207(2):197-204. PubMed ID: 18656047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
    Kapiteijn E; Putter H; van de Velde CJ;
    Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
    Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
    Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic versus open surgery for rectal cancer: long-term oncologic results.
    Laurent C; Leblanc F; Wütrich P; Scheffler M; Rullier E
    Ann Surg; 2009 Jul; 250(1):54-61. PubMed ID: 19561481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume-outcome analysis of colorectal cancer-related outcomes.
    Borowski DW; Bradburn DM; Mills SJ; Bharathan B; Wilson RG; Ratcliffe AA; Kelly SB;
    Br J Surg; 2010 Sep; 97(9):1416-30. PubMed ID: 20632311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of laparoscopic surgery on the long-term outcomes for patients with rectal cancer.
    Kim JG; Heo YJ; Son GM; Lee YS; Lee IK; Suh YJ; Cho HM; Chun CS
    ANZ J Surg; 2009 Nov; 79(11):817-23. PubMed ID: 20078533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery.
    Pucciarelli S; Del Bianco P; Toppan P; Serpentini S; Efficace F; Pasetto LM; Friso ML; De Salvo GL; Nitti D
    Ann Surg Oncol; 2008 Jul; 15(7):1846-54. PubMed ID: 18459006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of blood transfusions on recurrence and survival after rectal cancer surgery.
    Jagoditsch M; Pozgainer P; Klingler A; Tschmelitsch J
    Dis Colon Rectum; 2006 Aug; 49(8):1116-30. PubMed ID: 16779711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Local tumor control and (disease-free) survival after surgery with pre- and intraoperative radiotherapy for primary non-resectable rectal carcinoma and local recurrence].
    Mannaerts GH; Martijn H; Rutten HJ; Hanssens PE; Wiggers T
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1460-6. PubMed ID: 11503316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.
    Vecchio FM; Valentini V; Minsky BD; Padula GD; Venkatraman ES; Balducci M; Miccichè F; Ricci R; Morganti AG; Gambacorta MA; Maurizi F; Coco C
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):752-60. PubMed ID: 15936556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study.
    Shahir MA; Lemmens VE; van de Poll-Franse LV; Voogd AC; Martijn H; Janssen-Heijnen ML
    Eur J Cancer; 2006 Nov; 42(17):3015-21. PubMed ID: 16797967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of local surgery for rectal cancer.
    Folkesson J; Johansson R; Påhlman L; Gunnarsson U
    Br J Surg; 2007 Nov; 94(11):1421-6. PubMed ID: 17661311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are survival rates different for young and older patients with rectal cancer?
    O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
    Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.